Previous close | 0.5700 |
Open | N/A |
Bid | 0.4500 |
Ask | 0.7000 |
Strike | 135.00 |
Expiry date | 2024-08-02 |
Day's range | 0.5700 - 0.5700 |
Contract range | N/A |
Volume | |
Open interest | 1 |
Dexcom (DXCM) and Abbott are set to launch their first FDA-approved over-the-counter CGMs, Stelo and Lingo & Libre Rio, respectively, in the United States this summer.
Key Insights Using the 2 Stage Free Cash Flow to Equity, DexCom fair value estimate is US$113 DexCom's US$113 share...
Smart rings and smartwatches are providing consumers with reams of health information. Clinical device makers like DexCom needn’t worry.